Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

Diabeloop system demo @ #DData18 - DIABETESMINE UNIVERSITY

244 Aufrufe

Veröffentlicht am

A preview of the diabeloop closed loop system out of France at DIABETESMINE UNIVERSITY – our new innovation program that encompasses our annual Innovation Summit and D-Data ExChange forums, held Nov.1-2 at UCSF Mission Bay.

Veröffentlicht in: Gesundheitswesen
  • Als Erste(r) kommentieren

  • Gehören Sie zu den Ersten, denen das gefällt!

Diabeloop system demo @ #DData18 - DIABETESMINE UNIVERSITY

  1. 1. © 2018 Diabeloop – QA-TEMP-TM-Rev72018-10-22 #DDATA Demo #diabeloop 2018-11-02
  2. 2. Sommaire #DDATA Demo 2018-11-01 © 2018 Diabeloop – QA-TEMP-TM-Rev7 2 Diabeloop is a French independent company who develops disruptive technological innovations to automate the treatment of diabetes.
  3. 3. 2018-10-22 © 2018 Diabeloop – QA-TEMP-TM-Rev6 Our device : DBLG1 System 3
  4. 4. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 4 Comprehensive and personalized system for autonomous T1D management DBLG1 System has not yet received CE marking
  5. 5. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 5 Artificial Intelligence to safely automate insulin decisions SAFETY A.I. physiological framework Self-Learning short term + + Expert system Self-Learning long term
  6. 6. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 6 Built with & for PWD since day 1 Built with multiple groups of patients Through multiple clinical studies Features “invented” by PWD, not engineers 1. Patient-adjustable target & “aggressiveness” (e.g. hypo/average preference) 2. Always-connected, BUT patient chooses whom/when to send data to 3. Zen Mode 4. Confidentiality mode
  7. 7. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 7 Science 34 oral communications, papers in peer-reviewed journals and posters in significant conferences (ADA, EASD, ATTD,...) 9 patents (and 8 more being written) 150 million equations resolved per day 3 million lines of codes of the software 50,000 years of patient in-silico simulation 6 100 patient-days clinical trials - 80% in real life
  8. 8. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 SP7 intermediary results as presented at ADA 8 67 patients, 3 months, at home, parallel groups DBLG1 System has not yet received CE marking
  9. 9. #DDATA Demo 2018-11-02 © 2018 Diabeloop – QA-TEMP-TM-Rev7 Our company 9
  10. 10. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 10 Guillaume Charpentier, CERITD and CEA-LETI 2011 2012 2013 2014 20162015 2017 Proof of concept validation Ambulatory study 3 days 36 patients 9 centers Cross-over study 3 months 70 patients 12 centers Patient database Partnership with Dexcom CE Marking ISO 13485 Certification Team of 50 people in Paris & Grenoble 2018 Diabeloop story: an encounter between clinicians and technologists
  11. 11. © 2018 Diabeloop – QA-TEMP-TM-Rev7#DDATA Demo 2018-11-02 11 Diabeloop belongs to a close-knit network of partners 2012
  12. 12. @diabeloop www.diabeloop.com Thank You !

×